Elanco

Elanco Animal Health Incorporated
Company typePublic
IndustryPharmaceutical (animal)
Founded1954 Edit this on Wikidata
HeadquartersGreenfield, Indiana, U.S.
Key people
  • R. David Hoover (Chairman)
  • Jeff Simmons (CEO)
ProductsPharmaceutical drugs (animal)
RevenueIncrease US$4.765 billion (2021)[1]
Increase –US$0.567 billion (2021)[1]
Increase –US$0.472 billion (2021)[1]
Total assetsDecrease US$16.483 billion (2021)[1]
Total equityDecrease US$7.538 billion (2021)[1]
Number of employees
10,200 (2021)[2]
Websiteelanco.com

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.[3]

  1. ^ a b c d e "2021 Annual Report" (PDF). Elanco. 31 December 2021. Retrieved 17 March 2023.
  2. ^ "Elanco Animal Health Company Profile".
  3. ^ "Elanco Moving Global HQ to Indy". insideindianabusiness.com.